Browse By Region
Browse By Category
By Category: Countermeasures
(KGW) Fire crews, police and health officials in the Portland Metro area next week will simulate a terrorist attack involving a biological weapon. “The incident is simulated, the sickness and death imagined, yet all involved will take it very seriously,” said Port of Portland spokeswoman Kama Simonds.
- May 16, 2013
(GlobalBiodefense) The U.S Department of Homeland Security (DHS) has selected Health Research Inc. with the Wadsworth Center, New York State Department of Health to develop standard test methods to support field evaluation of technologies used for biological agent detection. The proposed work will address current gaps in standards by defining field testing needs, methods and Read More »
- May 15, 2013
(GlobalBiodefense) The National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories (RML) has been charged with performing integrated research requiring special positive protection suits for biological high containment laboratories.
- May 14, 2013
(GlobalBiodefense) Novavax, Inc. this week announced it has completed purification of a virus-like particle (VLP) vaccine candidate for the emerging H7N9 influenza and has initiated animal immunogenicity and efficacy studies.
- May 13, 2013
(ScienceDaily) The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International Inc., a U.S. based healthcare company, revealed it to be promising and well tolerated.
- May 13, 2013